Funded Startups in Zwijnaarde
Six recently recorded rounds in Zwijnaarde span 2020-07-27 to 2025-02-26, with the most recent being 4Tissue’s $1M seed on 2025-02-26.
Six recently recorded rounds in Zwijnaarde span 2020-07-27 to 2025-02-26, with the most recent being 4Tissue’s $1M seed on 2025-02-26. The disclosed amounts show a clear size outlier: Aphea.Bio’s $77M (2023-07-11) is the only round above $50M and it dwarfs the next-largest disclosed amounts ($42M on 2020-07-28 for ExeVir Bio, and $38M on 2020-07-27 for Indigo Diabetes).
Sectors cluster tightly: Biotechnology appears in 3 of the 6 entries (4Tissue 2025-02-26, RheaVita 2021-06-02, ExeVir Bio 2020-07-28), with the remaining entries split across Agriculture and Farming (Aphea.Bio, Series C on 2023-07-11) and Health Care (Indigo Diabetes, $38M on 2020-07-27). Stage labels are incomplete in 2 of the 6 rows: one “undisclosed” (Those Vegan Cowboys, 2024-06-11) and one blank stage field appears for RheaVita, ExeVir Bio, and Indigo Diabetes.
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round in Zwijnaarde here, and how does it compare with the rest of the disclosed amounts?
Aphea.Bio’s $77M on 2023-07-11 is the only disclosed round above $50M. The next-largest disclosed amounts are $42M (ExeVir Bio, 2020-07-28) and $38M (Indigo Diabetes, 2020-07-27), so the $77M round is dramatically larger than the rest of the disclosed set.
Are there noticeable sector over-representations in this 6-row Zwijnaarde slice?
Biotechnology is over-represented relative to other sectors, appearing in 3 of 6 entries: 4Tissue (2025-02-26, Seed, $1M), RheaVita (2021-06-02, amount $3M), and ExeVir Bio (2020-07-28, amount $42M). The remaining entries cover Agriculture and Farming (Aphea.Bio) and Health Care (Indigo Diabetes), each appearing once in the rows shown.
Do any rounds cluster into a short date window?
Yes, two of the six entries close within one day in late July 2020: ExeVir Bio on 2020-07-28 ($42M) and Indigo Diabetes on 2020-07-27 ($38M). Beyond that, the set is more spread out across 2020–2025, with no other tight multi-entry window at the date granularity shown.
How complete is the stage information across these companies?
Stage labeling is incomplete in 2 of 6 rows via explicit gaps/unknowns: Those Vegan Cowboys is marked “undisclosed” on 2024-06-11, while three other companies (RheaVita on 2021-06-02, ExeVir Bio on 2020-07-28, and Indigo Diabetes on 2020-07-27) have a blank stage field. Only 4Tissue (Seed on 2025-02-26) and Aphea.Bio (Series C on 2023-07-11) show non-blank stage classifications in the table.
Which entries look like outliers to screen first for diligence beyond biotech-focused patterns?
Those Vegan Cowboys (Food and Beverage) is an outlier on both sector and disclosure completeness: it is the only Food and Beverage entry and its 2024-06-11 amount is “undisclosed.” At the other extreme in disclosed size, Aphea.Bio’s $77M (2023-07-11, Agriculture and Farming, Series C) stands apart from the rest of the disclosed amounts that range from $1M to $42M.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.